Skip to content

Evaluation and Comparison of the Effectiveness of Corticosteroid Injection and Electroacupuncture in Controlling Pain and Improving Performance in Patients with Lateral Epicondylitis (Tennis Elbow)

Evaluation and Comparison of the Effectiveness of Corticosteroid Injection and Electroacupuncture in Controlling Pain and Improving Performance in Patients with Lateral Epicondylitis (Tennis Elbow)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191002044951N2
Enrollment
44
Registered
2025-05-29
Start date
2025-05-23
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral epicodylitis. Lateral epicondylitis

Interventions

Intervention 1: Intervention group: Corticosteroid Injection Group (Group 1):Participants in this group will receive a single corticosteroid injection. The corticosteroid used will be triamcinolone ac

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults aged between 18 and 65 years Clinically diagnosed with lateral epicondylitis (tennis elbow) for at least 6 weeks. Experiencing pain that has not responded to conservative treatments (e.g., rest, physiotherapy). the Visual Analog Scale = 4 (VAS; 0–10) at baseline. Ability to provide informed consent.

Exclusion criteria

Exclusion criteria: Occurrence of serious adverse events resulting from therapeutic interventions (such as infection, severe reaction to injection, or electroacupuncture). Non-compliance with post-treatment instructions:a) In the injection group: engaging in intense physical activities during the restricted period after injection.b) In the electroacupuncture group: failure to follow recommendations regarding rest or proper use of the treated limb. Lack of patient cooperation in continuing treatment sessions or scheduled evaluations. Emergence of new medical conditions that may affect the study outcomes (e.g., surgery or acute illnesses). Patient’s decision to withdraw from the study at any time, even after signing the informed consent. Investigator’s judgment that continued participation may pose a risk to the patient’s health.

Design outcomes

Primary

MeasureTime frame
Pain according to VAS score and PRTEE. Timepoint: The outcomes are assessed at three time points: at baseline, 3 months, and 6 months after the intervention. Method of measurement: VAS score and PRTEE.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKourosh Mansory

Iran University of Medical Sciences

Mansoori.k@iums.ac.ir+98 912 375 2812

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026